Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2026-01-05 @ 11:03 PM
Study NCT ID:
NCT03957551
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-21
First Post:
2019-05-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma
Sponsor:
John Rieth
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
201904712
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None